Larkspur Biosciences
Biotechnology Research
One Canal Park
17 employees
- Employees
- 17
- Contacts
- 3
- Emails
- 3
Larkspur Biosciences Overview
- Headquarters
- One Canal Park
- Website
- larkspur.bio
- Industry
- Biotechnology Research
- Employees
- 17
- Founded
- 2020
- Funding
- 35.5M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Larkspur Biosciences
Targeting enzymes that control cancer cell state and fitness make cancer cells susceptible to intrinsic and immune-mediated killing but drugging these pathways has been limited by poor tractability. Larkspur develops small molecules that overcome these limitations, decreasing cancer cell fitness and sensitizing them to intrinsic and immune-driven mechanisms of killing. LarkX, our proprietary machine-learning-enabled gene signature platform, identifies pathways with cancer cell-intrinsic adaptations that drive immune evasion. This identifies novel targets that mediate pathological cell-to-cell communication. Larkspur’s clinical development focuses on biomarker-driven cancer patient cohorts to achieve early proof-of-concept. Our first-in-class pipeline programs are initially focused on colorectal cancer (CRC), with opportunities to expand to multiple cancers. We believe that transformational discoveries are found at the interface between disciplines. With a proven track record of drug discovery and development, our team is passionate about solving hard problems and driven to deliver new medicines to cancer patients with significant unmet needs. At Larkspur, we grow together, building a culture that highly values joy, trust, and courage.
Larkspur Biosciences Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
Larkspur Biosciences Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Krista Goodman | Chief Scientific Officer, Larkspur | Cambridge, Massachusetts, United States |
Email
|
| S. Frank Yan | Shanghai, China |
Email
|
|
| Sydney Alnemy | Scientist Ii, in Vitro Pharmacology | Watertown, Massachusetts, United States |
Email
|
| Jared Haney | ⭐ Financial Planning & Analysis Manager | Auburn, New Hampshire, United States |
View
|
Employees by Management Level
Executive
1 profile
Manager
1 profile
Individual contributor
1 profile
Compare Similar Companies to Larkspur Biosciences
Orna Therapeutics
Biotechnology Research
Candel Therapeutics
Biotechnology Research
NOETIK
Biotechnology Research
Incendia Therapeutics
Biotechnology Research
Kira Pharmaceuticals
Biotechnology Research
Droplet Biosciences, Inc
Biotechnology
Unravel Biosciences
Biotechnology Research
Kano Therapeutics
Biotechnology Research
Cirrus Therapeutics
Biotechnology Research
Cyclera Therapeutics
Biotechnology Research